Patent · US Active

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds

US10570168B2 · kind B2 · utility

4Cited by
12References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 27, 2015
Grant dateFeb 25, 2020
Priority date
Expiry dateDec 22, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/207
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed are chemical compounds, the compounds for use in a method of treatment, particularly in a method of prophylaxis or treatment for cancer, a process for preparation of the compounds and pharmaceutical compositions comprising the compounds. The compounds may, in particular, be useful in the treatment of leukaemia, lymphoma and/or solid tumours in homo sapiens. The compounds are derivatives of cordycepin (3′-deoxyadenosine) having a 2′ and/or 5′-amino-acid ester phosphoramidate moiety.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.